# LAS Vegas Sands Corp: overview

LVS · NYSE · CIK 1300514 · [Consumer discretionary](/sectors/consumer-discretionary.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/lvs.md) · [Financials](/companies/lvs/financials.md) · [Filings](/companies/lvs/filings.md) · [Insiders](/companies/lvs/insiders.md)

Latest reported revenue: [$3.22bn](/filings/0001300514-26-000103.md) for Q3 FY2026, three months to 2026-09-30, from the 10-Q filed Oct 23, 2026 (XBRL us-gaap:Revenues, accession 0001300514-26-000103).

## Last eight quarters

| Line item | Unit | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [2,896](/filings/0001300514-26-000013.md) | [2,862](/filings/0001300514-26-000046.md) | [3,175](/filings/0001300514-26-000085.md) | [3,331](/filings/0001300514-26-000103.md) | [3,649](/filings/0001300514-26-000013.md) | [3,585](/filings/0001300514-26-000046.md) | [3,154](/filings/0001300514-26-000085.md) | [3,216](/filings/0001300514-26-000103.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | [20.4%](/filings/0001300514-26-000013.md) | [21.3%](/filings/0001300514-26-000046.md) | [24.7%](/filings/0001300514-26-000085.md) | [21.6%](/filings/0001300514-26-000103.md) | [19.4%](/filings/0001300514-26-000013.md) | [25.2%](/filings/0001300514-26-000046.md) | [19.6%](/filings/0001300514-26-000085.md) | [19.2%](/filings/0001300514-26-000103.md) |
| Net margin | % | [11.2%](/filings/0001300514-26-000013.md) | [12.3%](/filings/0001300514-26-000046.md) | [14.5%](/filings/0001300514-26-000085.md) | [12.6%](/filings/0001300514-26-000103.md) | [10.8%](/filings/0001300514-26-000013.md) | [15.8%](/filings/0001300514-26-000046.md) | [11.0%](/filings/0001300514-26-000085.md) | [9.5%](/filings/0001300514-26-000103.md) |
| Diluted EPS | $ per share | [0.45](/filings/0001300514-26-000013.md) | [0.49](/filings/0001300514-26-000046.md) | [0.66](/filings/0001300514-26-000085.md) | [0.61](/filings/0001300514-26-000103.md) | [0.58](/filings/0001300514-26-000013.md) | [0.85](/filings/0001300514-26-000046.md) | [0.53](/filings/0001300514-26-000085.md) | [0.48](/filings/0001300514-26-000103.md) |
| Free cash flow | $m | [368 d](/filings/0001300514-26-000013.md) | [147](/filings/0001300514-26-000046.md) | [(108) d](/filings/0001300514-26-000085.md) | [886 d](/filings/0001300514-26-000103.md) | [930 d](/filings/0001300514-26-000013.md) | [537](/filings/0001300514-26-000046.md) | [350 d](/filings/0001300514-26-000085.md) | [589 d](/filings/0001300514-26-000103.md) |

- Revenue. XBRL Revenue: us-gaap:Revenues.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:Revenues.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:Revenues.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 12-month figure less the 9-month figure; 6-month figure less the 3-month figure; 9-month figure less the 6-month figure.

## Last five fiscal years

| Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $bn | [4.2](/filings/0001300514-24-000048.md) | [4.1](/filings/0001300514-25-000040.md) | [10.4](/filings/0001300514-26-000013.md) | [11.3](/filings/0001300514-26-000013.md) | [13.0](/filings/0001300514-26-000013.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | [(16.3%)](/filings/0001300514-24-000048.md) | [(19.3%)](/filings/0001300514-25-000040.md) | [22.3%](/filings/0001300514-26-000013.md) | [21.3%](/filings/0001300514-26-000013.md) | [21.6%](/filings/0001300514-26-000013.md) |
| Net margin | % | [(22.7%)](/filings/0001300514-24-000048.md) | [44.6%](/filings/0001300514-25-000040.md) | [11.8%](/filings/0001300514-26-000013.md) | [12.8%](/filings/0001300514-26-000013.md) | [12.5%](/filings/0001300514-26-000013.md) |
| Diluted EPS | $ per share | [(1.26)](/filings/0001300514-24-000048.md) | [2.40](/filings/0001300514-25-000040.md) | [1.60](/filings/0001300514-26-000013.md) | [1.96](/filings/0001300514-26-000013.md) | [2.35](/filings/0001300514-26-000013.md) |
| Free cash flow | $bn | [(1.1)](/filings/0001300514-24-000048.md) | [(1.6)](/filings/0001300514-25-000040.md) | [2.2](/filings/0001300514-26-000013.md) | [1.6](/filings/0001300514-26-000013.md) | [1.9](/filings/0001300514-26-000013.md) |

- Revenue. XBRL Revenue: us-gaap:Revenues.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:Revenues.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:Revenues.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment; Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/lvs/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $1.15bn | 24,844,440 |  | Reduced −1,317,841 |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $898.2m | 19,446,065 |  | Reduced −192,334 |
| [VANGUARD PORTFOLIO MANAGEMENT LLC](/funds/2100121.md) | 2026-06-30 | $861.2m | 18,645,697 |  | Added +261,454 |
| [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $700.2m | 15,159,570 |  | Added +919,452 |
| [D. E. Shaw & Co., Inc.](/funds/1009207.md) | 2026-06-30 | $418.1m | 9,052,131 |  | Added +514,715 |
| [Invesco Ltd.](/funds/914208.md) | 2026-06-30 | $408.8m | 8,851,302 |  | Added +1,436,501 |
| [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $377.5m | 8,204,874 |  | Reduced −249,956 |
| [ARROWSTREET CAPITAL, LIMITED PARTNERSHIP](/funds/1164508.md) | 2026-06-30 | $341.1m | 7,384,543 |  | Reduced −1,198,419 |
| [Bank of New York Mellon Corp](/funds/1390777.md) | 2026-06-30 | $305.5m | 6,613,940 |  | Reduced −252,175 |
| [AQR CAPITAL MANAGEMENT LLC](/funds/1167557.md) | 2026-06-30 | $267.5m | 5,804,100 |  | Reduced −1,747,781 |

## Recent filings

[All 1,043 filings](/companies/lvs/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-27 | 20:32 ET | [8-K](/filings/0001300514-26-000112.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001300514-26-000112 |
| 2026-10-23 | 16:09 ET | [10-Q](/filings/0001300514-26-000103.md) | Quarterly report, period 2026-09-30 | 0001300514-26-000103 |
| 2026-10-21 | 16:08 ET | [8-K](/filings/0001300514-26-000099.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001300514-26-000099 |
| 2026-08-11 | 18:36 ET | [SCHEDULE 13D/A](/filings/0001193125-26-345232.md) | Ownership report, active investor, amended | 0001193125-26-345232 |
| 2026-07-24 | 16:03 ET | [10-Q](/filings/0001300514-26-000085.md) | Quarterly report, period 2026-06-30 | 0001300514-26-000085 |
| 2026-07-22 | 16:09 ET | [8-K](/filings/0001300514-26-000078.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001300514-26-000078 |
| 2026-06-18 | 20:02 ET | [SCHEDULE 13D/A](/filings/0001193125-26-276271.md) | Ownership report, active investor, amended | 0001193125-26-276271 |
| 2026-05-18 | 16:04 ET | [8-K](/filings/0001300514-26-000073.md) | 5.07 Shareholder vote results | 0001300514-26-000073 |
| 2026-05-13 | 16:09 ET | [8-K](/filings/0001300514-26-000070.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001300514-26-000070 |
| 2026-05-05 | 17:20 ET | [8-K](/filings/0001300514-26-000062.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001300514-26-000062 |

## Latest annual report

[Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001300514-26-000013.md), filed Feb 6, 2026.

## Forecast league

Not in this season’s league. [This season’s league](/leagues.md)

## About the filer

- CIK: 1300514
- Tickers: LVS
- Exchange: NYSE
- SIC code: 7011 Hotels & Motels
- State of incorporation: NV
- Filer category: Large accelerated filer

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 28, 2026, 06:03 ET. No prices; not investment advice.